Chugai Pharmaceutical Co.
中外製薬
What the record establishes
Wikidata records this company as “Chugai Pharmaceutical Co.”, described as “Switzerland company in Japan”. The record dates its founding to 1925. Its headquarters is recorded in Tokyo. The record reports 6,872 employees. The item is Q750619 in Wikidata’s CC0 structured data, checked 2026-11-18. The record classifies it as: business, enterprise, public company.
The record does not carry product catalogues or financial results, and this profile does not invent them. What can be checked is the record itself, linked below.
About Chugai Pharmaceutical Co.
Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, Chūgai Seiyaku kabushiki gaisha) is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO.
History
Timeline
This is a timeline of important events of Chugai Pharmaceutical.
1925: Juzo Ueno founded Chugai Shinyaku Co. Ltd. and started importing and selling medicines
1927: Start of the first own production
1930: Salobrocanon, an analgesic (pain reliever ) and antipyretic, is launched
1937: Calcium bromide production begins
1943: Name changed to Chugai Pharmaceutical Co., Ltd. based in Tokyo
1944: Acquisition of Matsunaga Pharmaceutical Ltd. and construction of a plant in Matsunaga
1945: The headquarters, the factories in Ikebukuro, Sakai and Takada were destroyed in World War II, the headquarters were relocated to Takada, the factory in Takada was rebuilt
1946: Construction of the plant in Kamagiishi
1951: Guronsan, a drug to detoxify and restore liver function, is launched
1952: Varsan, a perspiration insecticide, is launched
1955: Chugai became a public company.
1956: The stock is listed on the Tokyo Stock Exchange
1957: Construction of the Ukima plant
1960: Establishment of a research center (Takada Research Laboratory, Tokyo)
1967: Foundation of Fukushima Kasai Co Ltd.
1961 – Developed patents for synthesis of vitamin A
1969: The name of Fukushima Kasai Co Ltd. is changed to Eiko Kasei Co Ltd., after the merger of Fukushima Kasai Co Ltd. and Fukuma Kasau Co. Ltd.
1971: Construction of the factory in Fujieda
1975: Picibanil, a cancer drug, is launched
1982: Opening of a branch in New York
1986: Opening of a branch in London
1989: Acquisition of Gen-Probe Incorporated (USA)
1990: Epogin launched
1995 – Released acute promyelocytic sphere of leukemia drug treatment Vesanoid
1996 – Released anti-viral chemotherapeutic agent Hivid (HIV reverse transcriptase inhibitor)
1997 – Released HIV protease inhibitor Invirase
1999 – Released immunosuppressive agent Cellcept
2000 – Released antiemetic drug Kytril, developed to combat the side effects of chemotherapy
2001 – Produced anti-influenza virus Tamiflu (Roche)
2002: Start of the alliance with Roche
2003: Xeloda, a cancer drug, is launched
2005: Actemra launched
2007: Copegus, an antiviral, Avastin, a cancer drug, and Tarceva, a cancer drug launched
2011 – Produced Actemra, a human IL-6 receptor monoclonal antibody for rheumatoid arthritis
2014: Launch of Kadcyla, a cancer drug, Chugai Pharma China Co Ltd. founded
2015 – In March the company announced it would co-commercialise Athersys's stem cell therapy for ischemic strokes in Japan. The deal could yield upwards of US$205 million.
2016: Cooperation between Osaka University and Chugai
2018: Tecentriq, a cancer drug, is launched
2020 – FDA approved satralizumab (Enspryng) for treatment of the orphan disease neuromyelitis optica
Text adapted from Wikipedia (“Chugai”), published under CC BY-SA 4.0. Source article
At a glance
- Typebusiness, enterprise, public company
- Founded1925
- HeadquartersTokyo
- Employees6,872
- Listed onTokyo Stock Exchange (4519)
- Official websitehttps://www.chugai-pharm.co.jp
About the logo
The image on this page is the company’s logo as held by Wikimedia Commons, file “Chugai Pharmaceutical.svg”, credited to Chugai Pharmaceutical Vectorization: Kopiersperre and published under Public domain. A logo is shown because it belongs to this company by definition; no photograph is used unless the Commons record itself ties the photograph to this company.
Planning from the record
The record carries an official website, linked below. Products, offices and contact details change, so treat that site — not this profile — as the current source. This profile is built from open records and does not establish today’s operating state.
Sources and next steps
Original English profile generated from Wikidata and Wikimedia Commons records · Sources reviewed 18 November 2026. Operational details can change.
- DiscoverSwitzerland company in Japan
- NoticeFounded: 1925
- RememberTokyo
Exhibits and access can change. This preview does not offer product procurement, commercial specifications or live visitor information.
Chugai Pharmaceutical Co. — company logo Chugai Pharmaceutical Vectorization: Kopiersperre · Public domain · Photo details
Official source · Source checked 2026-11-18 · Original English profile